ArticleBone marrow transplantation2026

Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.

Linda Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.